Global Personalized Medicine Diagnostics Market 2012-2016

Global Personalized Medicine Diagnostics Market 2012-2016

Category : Diagnostic and Biotech

TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Personalized Medicine Diagnostics market to grow at a CAGR of 4.43 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for personalized medicine for treating cancer. The Global Personalized Medicine Diagnostics market has also been witnessing an increase in the number of industrial activities. However, the low awareness of personalized medicine diagnostics in developing countries could pose a challenge to the growth of this market. 
TechNavio's report, the Global Personalized Medicine Diagnostics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Personalized Medicine Diagnostics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMerieux SA, Illumina Inc., and Roche Holding AG.
The other vendors mentioned in this report are 20/20 GeneSystems Inc., Accumetrics Inc., AdvanDx Inc., Affymetrix Inc., Almac Group Ltd., AltheaDx Inc., Ambry Genetics Corp., Amgen Inc., Arrayit Corp., AssureRx Health Inc., Autogenomics Inc., BG Medicine Inc., Biocare Medical LLC, Biocartis SA, Biocept Inc., BioCurex Inc., Biodesix Inc., Bio-Reference Laboratories Inc., CombiMatrix Corp., Corgenix Medical Corp., DxTerity Diagnostics Inc., EnzoBiochem Inc., Epigenomics AG, Euroimmun AG, GE Healthcare, Genomic Health Inc., Interleukin Genetics Inc., Johnson & Johnson, Knome Inc., Lab21 Ltd., Life Technologies Corp., MDxHealth SA, Myriad Genetics Inc., Nanosphere Inc., Pathway Genomics Corp., Power3 Medical Products Inc., Quest Diagnostics Inc., Response Genetics Inc., Rosetta Genomics Ltd., Sequenom Inc., Trovagene Inc., Vermillion Inc., and Viracor-IBT Laboratories Inc..
Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

 

 

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology


Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

Product Offerings

06. Market Landscape

06.1 Market Size and Forecast

07. Key Market Segmentation

07.1 Global Personalized Medicine Diagnostics Market in Diabetes

Market Size and Forecast

Key Market Segmentation of Personalized Medicine Diagnostics in Diabetes

07.2 Global Personalized Medicine Diagnostics Market in Cancer

Market Size and Forecast

Key Market Segmentation of Personalized Medicine Diagnostics in Cancer

07.3 Global Personalized Medicine Diagnostics Market in Microbiology

Market Size and Forecast

07.4 Global Personalized Medicine Diagnostics Market in Cardiovascular Diseases

Market Size and Forecast

Key Market Segmentation of Personalized Medicine Diagnostics in Cardiovascular Diseases

07.5 Global Personalized Medicine Diagnostics Market in Coagulation Therapy

Market Size and Forecast

Key Market Segmentation of Personalized Medicine Diagnostics in Coagulation Therapy

07.6 Global Personalized Medicine Diagnostics Market in Infectious Diseases

Market Size and Forecast

Key Market Segmentation of Personalized Medicine Diagnostics in Infectious Diseases

07.7 Global Personalized Medicine Diagnostics Market in Organ Transplant Management

Market Size and Forecast

07.8 Global Personalized Medicine Diagnostics Market in Psychiatric Disorders

Market Size and Forecast

07.9 Global Personalized Medicine Diagnostics Market in Blood Transfusion

Market Size and Forecast

07.10 Five Forces Analysis

08. Geographical Segmentation

09. Key Leading Countries


USA

Germany

Japan

10. Vendor Landscape

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Key Vendor Analysis


17.1 Abbott Laboratories

Business Overview

Key Information

SWOT Analysis

17.2 AstraZeneca plc

Business Overview

Key Information

SWOT Analysis

17.3 Becton Dickinson and Company

Business Overview

Key Information

SWOT Analysis

17.4 bioMerieux SA

Business Overview

Key Information

SWOT Analysis

17.5 Novartis AG

Business Overview

Key Information

SWOT Analysis

17.6 Roche Holding AG

Business Overview

Key Information

SWOT Analysis

18. Other Reports in this Series





List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Personal Medicine Diagnostics Market 2012-2016 (US$ million)

Exhibit 3: Global Personalized Medicine Diagnostics Market by Segmentation

Exhibit 4: Global Personalized Medicine Diagnostics Market by Segmentation 2012

Exhibit 5: Global Personalized Medicine Diagnostics Market in Diabetes 2012-2016 (US$ million)

Exhibit 6: Global Personalized Medicine Diagnostics Market in Diabetes by Segmentation

Exhibit 7: Global Personalized Medicine Diagnostics Market in Diabetes by Segmentation 2012

Exhibit 8: Global Personalized Medicine Diagnostics Market in Diabetes by Segmentation 2012-2016

Exhibit 9: Global Personal Medicine Diagnostics Market in Blood Glucose Monitoring 2012-2016 (US$ million)

Exhibit 10: Global Personal Medicine Diagnostics Market in HbA1c Monitoring 2012-2016 (US$ million)

Exhibit 11: Global Personalized Medicine Diagnostics Market in Cancer 2012-2016 (US$ million)

Exhibit 12: Global Personalized Medicine Diagnostics Market in Diabetes by Segmentation

Exhibit 13: Global Personalized Medicine Diagnostics Market in Cancer by Segmentation 2012

Exhibit 14: Global Personal Medicine Diagnostics Market in Pharmacodiagnostic Histology 2012-2016 (US$ million)

Exhibit 15: Global Personal Medicine Diagnostics Market in Flow Cytometry 2012-2016 (US$ million)

Exhibit 16: Global Personal Medicine Diagnostics Market in Tumor Markers 2012-2016 (US$ million)

Exhibit 17: Global Personal Medicine Diagnostics Market in HPV 2012-2016 (US$ million)

Exhibit 18: Global Personal Medicine Diagnostics Market in Molecular Assays 2012-2016 (US$ million)

Exhibit 19: Global Personal Medicine Diagnostics Market in Circulating Tumor Cells 2012-2016 (US$ million)

Exhibit 20: Global Personalized Medicine Diagnostics Market in Microbiology 2012-2016 (US$ million)

Exhibit 21: Global Personalized Medicine Diagnostics Market in Cardiovascular Diseases 2012-2016 (US$ million)

Exhibit 22: Global Personalized Medicine Diagnostics Market in Cardiovascular Diseases by Segmentation

Exhibit 23: Global Personalized Medicine Diagnostics Market in Cardiovascular Diseases by Segmentation 2012

Exhibit 24: Global Personalized Medicine Diagnostics Market in Cardiovascular Diseases by Segmentation 2012-2016

Exhibit 25: Global Personal Medicine Diagnostics Market in Immunoassay Cardiac Markers (US$ million)

Exhibit 26: Global Personal Medicine Diagnostics Market in Cardiac Risk Markers (US$ million)

Exhibit 27: Global Personal Medicine Diagnostics Market in Molecular Cardiac Markers (US$ million)

Exhibit 28: Global Personalized Medicine Diagnostics Market in Coagulation Therapy 2012-2016 (US$ million)

Exhibit 29: Global Personalized Medicine Diagnostics Market in Coagulation Therapy by Segmentation

Exhibit 30: Global Personalized Medicine Diagnostics Market in Coagulation Therapy by Segmentation 2012

Exhibit 31: Global Personalized Medicine Diagnostics Market in Coagulation Therapy by Segmentation 2012-2016

Exhibit 32: Global Personal Medicine Diagnostics Market in Routine Coagulation (US$ million)

Exhibit 33: Global Personal Medicine Diagnostics Market in Molecular Coagulation (US$ million)

Exhibit 34: Global Personalized Medicine Diagnostics Market in Infectious Diseases 2012-2016 (US$ million)

Exhibit 35: Global Personalized Medicine Diagnostics Market in Infectious Diseases by Segmentation

Exhibit 36: Global Personalized Medicine Diagnostics Market in Infectious Diseases by Segmentation 2012

Exhibit 37: Global Personal Medicine Diagnostics Market in Viral Load HBV (US$ million)

Exhibit 38: Global Personal Medicine Diagnostics Market in Molecular HAI (US$ million)

Exhibit 39: Global Personal Medicine Diagnostics Market in Sepsis Immunoassay (US$ million)

Exhibit 40: Global Personal Medicine Diagnostics Market in CD4 HIV (US$ million)

Exhibit 41: Global Personal Medicine Diagnostics Market in Viral Load HIV (US$ million)

Exhibit 42: Global Personal Medicine Diagnostics Market in Viral Load HCV (US$ million)

Exhibit 43: Global Personal Medicine Diagnostics Market in MDR-TB (US$ million)

Exhibit 44: Global Personalized Medicine Diagnostics Market in Organ Transplant Management 2012-2016 (US$ million)

Exhibit 45: Global Personalized Medicine Diagnostics Market in Psychiatric Disorders 2012-2016 (US$ million)

Exhibit 46: Global Personalized Medicine Diagnostics Market in Blood Transfusion 2012-2016 (US$ million)

Exhibit 47: Global Personalized Medicine Diagnostics Market by Geographical Segmentation 2012

Exhibit 48: Business Segmentation of Abbott Laboratories

Exhibit 49: Business Segmentation of AstraZeneca plc

Exhibit 50: Business Segmentation of Becton Dickinson and Company

Exhibit 51: Business Segmentation of bioMerieux SA

Exhibit 52: Business Segmentation of Novartis AG

Exhibit 53: Business Segmentation of Roche Holding AG

Exhibit 54: Roche Pharmaceuticals Segment Sales in FY2012

Exhibit 55: Roche Diagnostics Segment Sales in FY2012





 



Enquiry Before Buy